1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Systemic lupus erythematosus

Belimumab for treating lupus nephritis (terminated appraisal)

Technology appraisal [TA806] Published: 13 July 2022

  • Guidance
  • Tools and resources
  • History

History

A list of downloadable documents created during development.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators  
  • Draft scope post referral PDF 191 KB 06 July 2021  
  • Draft matrix post referral PDF 162 KB 06 July 2021